Jeremy Caldwell

Partner, Red Tree Venture Capital

Mira Chaurushiya

Managing Director

Westlake Village BioPartners

John Connolly

Chief Scientific Officer, Parker Institute for Cancer Immunology

Neel Desai

Business Development and Licensing, Biogen

Karen Deschaine (Moderator)

Corporate Life Sciences Partner, Wilson Sonsini Goodrich & Rosati

Richard DiMarchi

Professor, Indiana University

Dalton Einhorn

Global Head of Pharmaceutical Corporate Venture Capital, Asahi Kasei Pharma

Dan Estes

General Partner, Frazier Healthcare Partners

Simone Fishburn (Moderator)

Editor in Chief, BioCentury Inc.

William Haddad (Moderator)

Partner, Venable LLP

Richard Heyman, Ph.D.

Co-founder & Chairman of the Board

ORIC Pharmaceuticals

Andrea Houghton

VP Global Head of Biology, Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson

Albert Hwang (Moderator)

Managing Director, Head of US Healthcare Investment Banking, Morgan Stanley

Kim Kamdar

Partner, Medical Excellence Capital

Jim Krenn (Moderator)

Partner, Morrison & Foerster

Rachna Khosla

Senior Vice President, Business Development, Amgen

Jennifer Leeds

Executive Director, Head NIBR BD&L Search and Evaluation, West Coast and Canada, Novartis

John Lepore

CEO, ProFound Therapeutics; CEO-Partner, Flagship Pioneering

Nan Li

Co-Founder and Managing Partner

Dimension

Jay Lichter

Managing Director, Avalon Ventures; President and CEO, Arialys Therapeutics

Stuart Mackey

Global Head of Business Development, Daiichi Sankyo

Mathai Mammen

CEO, President and Chairman, FogPharma

Daniel Parisotto (Moderator)

Managing Director, Healthcare Banking, Oppenheimer

Konstantina Manjoros Katcheves

Senior Vice President Business Development, Bristol Myers Squibb

Peter Meinke

Sanders Director, Tri-Institutional Therapeutics Discovery Institute, Inc

Detlev Mennerich

Corporate SVP, Global Head of Business Development & Licensing, Boehringer Ingelheim

Mitchell Mutz

Entrepreneur Partner, Vivo Capital

Imran Nasrullah

VP & Head, Collaborate2Cure Hub, US, BD&L

Carolyn Ng

Partner and Managing Director, TPG Life Sciences Innovations

Carole Nuechterlein

Head, Roche Venture Fund

Sunil Patel

Head of Corporate Development and Business Development & Licensing, Merck

Emma Parmee

Global Head Therapeutics Discovery at The Janssen Pharmaceutical Companies of Johnson & Johnson

Danjuma Quarless

Associate Director, AbbVie Ventures, AbbVie

Jeremy Quirk

VP BD&L Commercial Portfolio, GSK

Visali Ramanathan

Senior Director, Business Development, Genentech

Brad Robling

Vice President, Lilly Ventures, Eli Lilly & Company

Christalyn Rhodes

Associate Vice President- Genetic Medicine, External Partnerships and Collaborations, Eli Lilly and Company

Camille Samuels

Partner, Venrock

Peter Schultz

Scripps Family Chair Professor, President and CEO, The Scripps Research Institute

Uwe Schoenbeck

Venture Partner, Cannan

Andy Schwab

Founder and Managing Partner, 5AM Ventures

Ben Sklaroff

CTO, Co-Founder, Genesis Therapeutics

Marshall Smith

Global Head of the Healthcare Group, Investment Banking Division, Goldman Sachs

Jay Stamatis, MBA

Vice President, Head of Business Development and Acquisitions, AbbVie

Tari Suprapto

Director, Search & Evalutation (West), Novo Nordisk

Philip Tagari

CSO, Insitro

Nancy Thornberry (Moderator)

Founding CEO and Chair, R&D, Kallyope

Daniel Tumas

VP, Head of Search and Evaluation, Gilead Sciences

Court Turner

Partner, LYZZ Capital Advisors

Michael Weingarten

Director of the Small Business Innovation Research Development Center, NCI SBIR Development Center

D.A. Wallach (Moderator)

General Partner, Co-Founder, Time BioVentures

Charity Williams (Moderator)

Partner, Cooley

Asish Xavier

Vice President, Venture Investments, Johnson & Johnson Innovation – JJDC